The Threat of Exploitation in the Adult Sex Market: A Pilot Study of Online Sex Worker Advertisements1
In: Policing: a journal of policy and practice, Band 12, Heft 2, S. 210-218
ISSN: 1752-4520
5 Ergebnisse
Sortierung:
In: Policing: a journal of policy and practice, Band 12, Heft 2, S. 210-218
ISSN: 1752-4520
In: Muehlbacher , A C , Juhnke , C , Beyer , A R & Garner , S 2016 , ' Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions : The European Union Perspective ' , Value in Health , vol. 19 , no. 6 , pp. 734-740 . https://doi.org/10.1016/j.jval.2016.04.006 ; ISSN:1098-3015
Regulatory decisions are often based on multiple clinical end points, but the perspectives used to judge the relative importance of those end points are predominantly those of expert decision makers rather than of the patient. However, there is a growing awareness that active patient and public participation can improve decision making, increase acceptance of decisions, and improve adherence to treatments. The assessment of risk versus benefit requires not only information on clinical outcomes but also value judgments about which outcomes are important and whether the potential benefits outweigh the harms. There are a number of mechanisms for capturing the input of patients, and regulatory bodies within the European Union are participating in several initiatives. These can include patients directly participating in the regulatory decision-making process or using information derived from patients in empirical studies as part of the evidence considered. One promising method that is being explored is the elicitation of "patient preferences." Preferences, in this context, refer to the individual's evaluation of health outcomes and can be understood as statements regarding the relative desirability of a range of treatment options, treatment characteristics, and health states. Several methods for preference measurement have been proposed, and pilot studies have been undertaken to use patient preference information in regulatory decision making. This article describes how preferences are currently being considered in the benefit-risk assessment context, and shows how different methods of preference elicitation are used to support decision making within the European context.
BASE
In: Policing: a journal of policy and practice, Band 13, Heft 4, S. 377-385
ISSN: 1752-4520
Abstract
This article explores the role of organized crime groups in persistent theft and shop theft. It is based on an analysis of police data using exploratory analytical techniques assessing the extent of connectivity between acquisitive offenders. The research also draws on qualitative data collected from interviews. The findings suggest that shop theft was predominantly committed by UK nationals; although foreign nationals were proportionately more likely to be involved in organized crime, there is some evidence that they may themselves be being exploited. The findings are discussed and suggestions for further research are made.
In: Bulletin of the World Health Organization: the international journal of public health = Bulletin de l'Organisation Mondiale de la Santé, Band 99, Heft 10, S. 715-721
ISSN: 1564-0604
Background: Surveillance of antimicrobial consumption (AMC) is important to address inappropriate use. AMC data for countries in the European Union (EU) and European Economic Area (EEA) and Eastern European and Central Asian countries were compared to provide future guidance. Methods: Analyses of 2014–2018 data from 30 EU/EEA countries of the European Surveillance of Antibiotic Consumption network (ESAC-Net) and 15 countries of the WHO Regional Office for Europe (WHO Europe) AMC Network were conducted using the Anatomical Therapeutic Chemical (ATC) classification and Defined Daily Dose (DDD) methodology. Total consumption (DDD per 1000 inhabitants per day) of antibacterials for systemic use (ATC group J01), relative use (percentages), trends over time, alignment with the WHO Access, Watch, Reserve (AWaRe) classification, concordance with the WHO global indicator (60% of total consumption should be Access agents), and composition of the drug utilization 75% (DU75%) were calculated. Findings: In 2018, total consumption of antibacterials for systemic use (ATC J01) ranged from 8.9 to 34.1 DDD per 1000 inhabitants per day (population-weighted mean for ESAC-Net 20.0, WHO Europe AMC Network 19.6, ESAC-Net Study Group, and WHO Europe AMC Network Study Group). ESAC-Net countries consumed more penicillins (J01C; 8.7 versus 6.3 DDD per 1000 inhabitants per day), more tetracyclines (J01A; 2.2 versus 1.2), less cephalosporins (J01D; 2.3 versus 3.8) and less quinolones (J01M; 1.7 versus 3.4) than WHO Europe AMC Network countries. Between 2014 and 2018, there were statistically significant reductions in total consumption in eight ESAC-Net countries. In 2018, the relative population-weighted mean consumption of Access agents was 57.9% for ESAC-Net and 47.4% for the WHO Europe AMC Network. For each year during 2014–2018, 14 ESAC-Net and one WHO Europe AMC Network countries met the WHO global monitoring target of 60% of total consumption being Access agents. DU75% analyses showed differences in the choices of agents in the two ...
BASE